These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 7003784

  • 1. Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease.
    Pardy BJ, Lewis JD, Eastcott HH.
    Surgery; 1980 Dec; 88(6):826-32. PubMed ID: 7003784
    [Abstract] [Full Text] [Related]

  • 2. The effect of intravenous prostacyclin on resting pains and healing of ischaemic ulcers in peripheral artery disease.
    Olsson AG, Nilsson E.
    Prostaglandins Med; 1981 Apr; 6(4):329-39. PubMed ID: 7025066
    [Abstract] [Full Text] [Related]

  • 3. Intravenous infusion of prostaglandin E1 (PGE1) in management of limb ischemia.
    Sethi GK, Bridgman AH, King L, Scott SM.
    Am Surg; 1986 Sep; 52(9):474-8. PubMed ID: 3752724
    [Abstract] [Full Text] [Related]

  • 4. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.
    Belch JJ, Newman P, Drury JK, McKenzie F, Capell H, Leiberman P, Forbes CD, Prentice CR.
    Lancet; 1983 Feb 12; 1(8320):313-5. PubMed ID: 6130329
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of the peripheral vascular diseases with prostaglandin].
    Miyauchi Y.
    Nihon Rinsho; 1994 Aug 12; 52(8):2182-6. PubMed ID: 7933609
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandin E1 infusion for small vessel arterial ischaemia.
    Clifford PC, Martin MF, Dieppe PA, Sheddon EJ, Baird RN.
    J Cardiovasc Surg (Torino); 1983 Aug 12; 24(5):503-8. PubMed ID: 6686232
    [Abstract] [Full Text] [Related]

  • 7. The use of prostaglandins PGE1 and PGI2 in peripheral arterial ischemia.
    Cronenwett JL.
    J Vasc Surg; 1986 Feb 12; 3(2):370-4. PubMed ID: 3511306
    [No Abstract] [Full Text] [Related]

  • 8. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR, Ramwell PW.
    Circ Shock; 1980 Feb 12; 7(3):299-308. PubMed ID: 7004660
    [Abstract] [Full Text] [Related]

  • 9. Clinical observations with intravenous prostaglandin E1 in peripheral vascular disease.
    Feldman SM, Alpert J, Dick LS, Brief DK, Goldenkranz R, Brener BJ, Parsonnet V.
    J Med Soc N J; 1982 Dec 12; 79(13):985-7. PubMed ID: 6961223
    [No Abstract] [Full Text] [Related]

  • 10. Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial.
    Belch JJ, McKay A, McArdle B, Leiberman P, Pollock JG, Lowe GD, Forbes CD, Prentice CR.
    Lancet; 1983 Feb 12; 1(8320):315-7. PubMed ID: 6130330
    [Abstract] [Full Text] [Related]

  • 11. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 Feb 12; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 12. Conservative treatment of inoperable arterial occlusions of the lower extremities with intra-arterial prostaglandin E1.
    Gruss JD, Bartels D, Ohta T, Machado JL, Schlechtweg B.
    Br J Surg; 1982 Jun 12; 69 Suppl():S11-3. PubMed ID: 7044465
    [Abstract] [Full Text] [Related]

  • 13. Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes.
    Nehler MR, Brass EP, Anthony R, Dormandy J, Jiao J, McNamara TO, Hiatt WR, Circulase investigators.
    J Vasc Surg; 2007 May 12; 45(5):953-60; discussion 960-1. PubMed ID: 17350216
    [Abstract] [Full Text] [Related]

  • 14. The intrainfusion platelet rebound during and following PGE1-infusion is faster and more intensive than that with PGI2.
    Sinzinger H, Reiter S.
    Prostaglandins Leukot Med; 1984 Mar 12; 13(3):281-8. PubMed ID: 6585847
    [Abstract] [Full Text] [Related]

  • 15. Salvage of the severely ischaemic limb by intra-arterial prostacyclin (PGI2) infusion. A case report.
    Søreide O, Segadal L, Trippestad A, Engedal H.
    Scand J Thorac Cardiovasc Surg; 1982 Mar 12; 16(1):71-3. PubMed ID: 7041251
    [Abstract] [Full Text] [Related]

  • 16. Failure to demonstrate beneficial effect of prostacyclin (PGI2) infusion on red blood cell deformability in patients with peripheral vascular disease: a possible role of the leukocytes.
    Parise P, Berrettini M, Grasselli S, de Cunto M, Nenci GG.
    Angiology; 1992 Apr 12; 43(4):320-7. PubMed ID: 1558317
    [Abstract] [Full Text] [Related]

  • 17. [Results of the treatment of peripheral arterial diseases with PGE1].
    Borkowski M, Kruk M, Królicki L, Wojtal E, Malmurowicz L, Górewicz R, Laszuk D.
    Pol Tyg Lek; 1992 Apr 12; 45(25-26):505-8. PubMed ID: 2287566
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with prostaglandin E1 in the treatment of arteriosclerosis obliterans. A preliminary report.
    Ambrus JL, Taheri P, Killion D, Donaldson G.
    J Med; 1983 Apr 12; 14(1):1-15. PubMed ID: 6577118
    [Abstract] [Full Text] [Related]

  • 19. Healing of ischaemic ulcers by intravenous prostaglandin E1 in a woman with thrombangitis obliterans.
    Olsson AG, Thyresson N.
    Acta Derm Venereol; 1978 Apr 12; 58(5):467-72. PubMed ID: 82360
    [No Abstract] [Full Text] [Related]

  • 20. The effect of intravitreal and topical prostaglandins on intraocular inflammation.
    Kulkarni PS, Srinivasan BD.
    Invest Ophthalmol Vis Sci; 1982 Sep 12; 23(3):383-92. PubMed ID: 7050005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.